MiMedx Group Inc (MDXG) support and resistance · P/E 18, rev $123.4M
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
This page maps MiMedx Group Inc (MDXG) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MDXG revenue for 2026-06-30 was $123.4M. Net income was -$25.7M. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.
MDXG currently screens at market cap $537.7M and trailing P/E 18.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MDXG 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MDXG quote page for the session range and the stock page for the full model.
Not investment advice.